Phase II study of the tetrahydropyranyl adriamycin–cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma

Senji KasaharaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Takeshi HaraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Hisashi TsurumiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, JapanCorrespondence[email protected]

Naoe GotoFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Jun-Ichi KitagawaDepartment of Hematology, Gifu Red-Cross Hospital, Gifu, Japan

Nobuhiro KanemuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Takeshi YoshikawaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Hideko GotoDepartment of Internal Medicine, Kisogawa Municipal Hospital, Kisogawa, Japan

Kenji FukunoDivision of Hematology, Gifu Municipal Hospital, Gifu, Japan

Toshiki YamadaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Michio SawadaDepartment of Hematology, Gifu Red-Cross Hospital, Gifu, Japan

Takeshi TakahashiDivision of Hematology, Gifu Municipal Hospital, Gifu, Japan

Tsuyoshi TakamiDepartment of Immunopathology, Gifu University Graduate School of Medicine, Gifu, Japan

Hisataka MoriwakiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Your download is now in progress and you may close this window